1. Home
  2. TCPC vs CTKB Comparison

TCPC vs CTKB Comparison

Compare TCPC & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCPC
  • CTKB
  • Stock Information
  • Founded
  • TCPC 2006
  • CTKB 1990
  • Country
  • TCPC United States
  • CTKB United States
  • Employees
  • TCPC N/A
  • CTKB N/A
  • Industry
  • TCPC Finance/Investors Services
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • TCPC Finance
  • CTKB Health Care
  • Exchange
  • TCPC Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • TCPC 603.8M
  • CTKB 508.9M
  • IPO Year
  • TCPC 2012
  • CTKB 2021
  • Fundamental
  • Price
  • TCPC $7.16
  • CTKB $4.15
  • Analyst Decision
  • TCPC Sell
  • CTKB Hold
  • Analyst Count
  • TCPC 2
  • CTKB 4
  • Target Price
  • TCPC $6.75
  • CTKB $6.00
  • AVG Volume (30 Days)
  • TCPC 523.9K
  • CTKB 1.1M
  • Earning Date
  • TCPC 08-07-2025
  • CTKB 08-06-2025
  • Dividend Yield
  • TCPC 16.92%
  • CTKB N/A
  • EPS Growth
  • TCPC N/A
  • CTKB N/A
  • EPS
  • TCPC N/A
  • CTKB N/A
  • Revenue
  • TCPC $239,535,768.00
  • CTKB $196,035,000.00
  • Revenue This Year
  • TCPC N/A
  • CTKB $0.09
  • Revenue Next Year
  • TCPC N/A
  • CTKB $7.45
  • P/E Ratio
  • TCPC N/A
  • CTKB N/A
  • Revenue Growth
  • TCPC 3.11
  • CTKB N/A
  • 52 Week Low
  • TCPC $6.27
  • CTKB $2.37
  • 52 Week High
  • TCPC $9.72
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • TCPC 46.41
  • CTKB 61.75
  • Support Level
  • TCPC $7.02
  • CTKB $4.02
  • Resistance Level
  • TCPC $7.17
  • CTKB $4.23
  • Average True Range (ATR)
  • TCPC 0.12
  • CTKB 0.16
  • MACD
  • TCPC 0.02
  • CTKB -0.01
  • Stochastic Oscillator
  • TCPC 66.67
  • CTKB 79.55

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: